Redefining blood collection and analysis


Seventh Sense Biosystems has designed and developed TAP™, the world’s first push-button blood collection device. It makes the process simple, convenient, and virtually painless. $50 billion is spent annually on diagnostics and consumers are demanding more from the healthcare system. The company aims to create a new standard for blood collection that increases patient compliance with testing orders, leading to faster diagnoses and better outcomes. Future versions of TAP will enable patients to collect their own blood anywhere.


Year Invested: 2008
Location: Cambridge, Mass.
Visit: www.7sbio.com

Recent News

February 23, 2017
First-Ever Device for Fast and Virtually Painless Blood Draw Receives FDA Clearance

November 18, 2016
Seventh Sense Biosystems Raises Series C Round of Funding

April 13, 2016
Seventh Sense Biosystems Launches Pivotal Trial For Groundbreaking TAP Diagnostic Blood Collection Device

Read More News

Associated Team Members

Neil Exter
Partner